发明授权
US07550478B2 Tyrosine kinase inhibitors 有权
酪氨酸激酶抑制剂

Tyrosine kinase inhibitors
摘要:
The present invention relates to 5H-benzo[4,5]cyclohepta[1,2-b]pyridine compounds, that are useful for treating cellular proliferative diseases, for treating disorders associated with MET activity, and for inhibiting the receptor tyrosine kinase MET. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
公开/授权文献
信息查询
0/0